Literature DB >> 8230486

Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen.

S B Hwang1, M M Lai.   

Abstract

Hepatitis delta antigen (HDAg) consists of two protein species of 195 and 214 amino acids, respectively, which are identical in sequence except that the large HDAg has additional 19 amino acids at its C terminus and is prenylated. Previous studies have shown that the large HDAg and the surface antigen of hepatitis B virus (HBsAg) together can form empty hepatitis delta virus (HDV) particles. To understand the molecular mechanism of HDV virion morphogenesis, we investigated the possible direct protein-protein interaction between HDAg and HBsAg. We constructed recombinant baculoviruses expressing the major form of HBsAg and various mutant HDAgs and used these proteins for far-Western protein binding assays. We demonstrated that HBsAg interacted specifically with the large HDAg but not with the small HDAg. Using mutant HDAgs which have defective or aberrant prenylation, we showed that this interaction required isoprenylates on the cysteine residue of the C terminus of the large HDAg. Isoprenylation alone, without the remainder of the C-terminal amino acids of the large HDAg, was insufficient to mediate interaction with HBsAg. This study demonstrates a novel role of prenylates in HDV virion assembly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230486      PMCID: PMC238236     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  The hepatitis delta (delta) virus possesses a circular RNA.

Authors:  A Kos; R Dijkema; A C Arnberg; P H van der Meide; H Schellekens
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

2.  Antigens of hepatitis delta virus in the liver and serum of humans and animals.

Authors:  K F Bergmann; J L Gerin
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication.

Authors:  M Chao; S Y Hsieh; J Taylor
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Structure, sequence and expression of the hepatitis delta (delta) viral genome.

Authors:  K S Wang; Q L Choo; A J Weiner; J H Ou; R C Najarian; R M Thayer; G T Mullenbach; K J Denniston; J L Gerin; M Houghton
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

6.  Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA.

Authors:  S Makino; M F Chang; C K Shieh; T Kamahora; D M Vannier; S Govindarajan; M M Lai
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

7.  Epidemiology and clinical impact of hepatitis D virus (delta) infection.

Authors:  I M Jacobson; J L Dienstag; B G Werner; D B Brettler; P H Levine; I K Mushahwar
Journal:  Hepatology       Date:  1985 Mar-Apr       Impact factor: 17.425

8.  Fulminant B viral hepatitis: role of delta agent.

Authors:  S Govindarajan; K P Chin; A G Redeker; R L Peters
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

9.  Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein.

Authors:  J H Ou; W J Rutter
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

10.  Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope.

Authors:  F Bonino; K H Heermann; M Rizzetto; W H Gerlich
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

View more
  37 in total

1.  Unique properties of the large antigen of hepatitis delta virus.

Authors:  G Moraleda; S Seeholzer; V Bichko; R Dunbrack; J Otto; J Taylor
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Identification and functional expression in yeast of a prenylcysteine alpha-carboxyl methyltransferase gene from Arabidopsis thaliana.

Authors:  D N Crowell; M Kennedy
Journal:  Plant Mol Biol       Date:  2001-03       Impact factor: 4.076

3.  Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication.

Authors:  Yi-Jia Li; Michael R Stallcup; Michael M C Lai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Large hepatitis delta antigen is a novel clathrin adaptor-like protein.

Authors:  Cheng Huang; Shin C Chang; I-Chen Yu; Yeou-Guang Tsay; Ming-Fu Chang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Clathrin-mediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus.

Authors:  Cheng Huang; Shin C Chang; Hui-Chin Yang; Chung-Liang Chien; Ming-Fu Chang
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

6.  Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen.

Authors:  S B Hwang; M M Lai
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

Review 7.  Hepatitis D and hepatocellular carcinoma.

Authors:  Zaigham Abbas; Minaam Abbas; Sarim Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2015-04-18

8.  Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Evolution and diversity of the human hepatitis d virus genome.

Authors:  Chi-Ruei Huang; Szecheng J Lo
Journal:  Adv Bioinformatics       Date:  2010-02-24

10.  The C-terminal sequence of the large hepatitis delta antigen is variable but retains the ability to bind clathrin.

Authors:  Yu-Cheng Wang; Chi-Ruei Huang; Mei Chao; Szecheng J Lo
Journal:  Virol J       Date:  2009-03-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.